ASA, CAFFEINE & 8MG CODEINE PHOSPHATE 15 MG
CAFFEINE : 15 MG ACETYLSALICYLIC ACID : 325 MG CODEINE PHOSPHATE : 8 MG · DIN 02238961 · CANAPHARM MANUFACTURING INC
Health Canada status: CANCELLED POST MARKET
What is ASA, CAFFEINE & 8MG CODEINE PHOSPHATE?
ASA, CAFFEINE & 8MG CODEINE PHOSPHATE 15 MG contains CAFFEINE : 15 MG ACETYLSALICYLIC ACID : 325 MG CODEINE PHOSPHATE : 8 MG. It is listed in the Health Canada Drug Product Database under DIN 02238961, held by CANAPHARM MANUFACTURING INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 25-Aug-2006. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is ASA, CAFFEINE & 8MG CODEINE PHOSPHATE called?
The same molecule, CODEINE AND ACETYLSALICYLIC ACID, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Brunacod | Latin | South Africa |
| Ibupain Forte | Latin | South Africa |
| Spectrapain | Latin | South Africa |
| Codef Cough | Latin | South Africa |
| Docsed | Latin | South Africa |
| Lenazine Forte | Latin | South Africa |
| Mybucod | Latin | South Africa |
| Suncodin Tablets | Latin | South Africa |
| ACTIFED COMPOUND LINCTUS | Latin | Saudi Arabia |
| Adco-Kiddipayne | Latin | South Africa |
| Adco-Metaxol | Latin | South Africa |
| AstraPain Syrup | Latin | South Africa |
| Ban Pain A/F | Latin | South Africa |
| Codeine | Latin | South Africa |
| CODETUX AD | Latin | Morocco |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02238961 |
|---|---|
| Brand name | ASA, CAFFEINE & 8MG CODEINE PHOSPHATE |
| Generic / active ingredient | CAFFEINE : 15 MG ACETYLSALICYLIC ACID : 325 MG CODEINE PHOSPHATE : 8 MG |
| Manufacturer | CANAPHARM MANUFACTURING INC |
| Strength | 15 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NARCOTICS (CDSA I) |
| ATC code | N02AJ07 CODEINE AND ACETYLSALICYLIC ACID |
| AHFS class | 28:08.08 ; 28:08.04.24 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 25-Aug-2006 |
| Original market date | 2000-03-13 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02238961 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2238961 |
| Brand name | ASA, CAFFEINE & 8MG CODEINE PHOSPHATE |
| Active ingredient / INN | CAFFEINE : 15 MG ACETYLSALICYLIC ACID : 325 MG CODEINE PHOSPHATE : 8 MG |
| ATC code | N02AJ07 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N02 |
| AHFS class | 28:08.08 ; 28:08.04.24 |
| Health Canada schedule | NARCOTICS (CDSA I) |
| Biosimilar biologic | No |
| Market authorization holder | CANAPHARM MANUFACTURING INC |
Which pack is which?
| Strength on the label | 15 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Is CODEINE AND ACETYLSALICYLIC ACID in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by PURDUE PHARMA, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
Check availability for ASA, CAFFEINE & 8MG CODEINE PHOSPHATE
What can be used instead?
Other Canadian products sharing ATC code N02AJ07 CODEINE AND ACETYLSALICYLIC ACID. 0 of 26 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| 222 TABLETS | 8 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | CANCELLED POST MARKET | DIN 00108162 |
| 282 TAB | 15 MG | TABLET | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | CANCELLED POST MARKET | DIN 00108103 |
| 282 TABLETS | 15 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 02234510 |
| 292 TAB | 30 MG | TABLET | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | CANCELLED POST MARKET | DIN 00219843 |
| 292 TABLETS | 15 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 02238645 |
| A & C TABLETS WITH CODEINE 15MG | 15 MG | TABLET | D.C. LABS LIMITED | CANCELLED POST MARKET | DIN 00095508 |
| A & C TABLETS WITH CODEINE 30MG | 30 MG | TABLET | D.C. LABS LIMITED | CANCELLED POST MARKET | DIN 00095516 |
| A.C. & C. 8 MG | 8 MG | TABLET | LABORATOIRES CONFAB INC | CANCELLED PRE MARKET | DIN 02245670 |
| A.C. & C. 8MG | 15 MG | TABLET | WESTCAN PHARMACEUTICALS LTD. | CANCELLED PRE MARKET | DIN 02230426 |
| A.C.& C TABLETS | 325 MG | TABLET | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 01922246 |
Who else supplies CODEINE AND ACETYLSALICYLIC ACID worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CODEINE AND ACETYLSALICYLIC ACID appears in 25 registered pack listings across 4 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does CODEINE AND ACETYLSALICYLIC ACID cost around the world?
CODEINE AND ACETYLSALICYLIC ACID is listed on 7 national price registers Nexara tracks, across 65 pack listings published on 7 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| South Africa | single exit price | 31 | 42 | 01 Sep 2026 |
| Morocco | PPV (public price) | 6 | 6 | 05 Sep 2026 |
| United Kingdom | hospital | 5 | 5 | 31 Aug 2026 |
| United States | acquisition | 3 | 5 | 03 Sep 2026 |
| Australia | ex-manufacturer | 1 | 4 | 08 Sep 2026 |
| Hungary | producer price (ex-factory) | 2 | 2 | 03 Sep 2026 |
| Saudi Arabia | public | 1 | 1 | 01 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.